In situ detection of global DNA hypomethylation in exfoliative urine cytology of patients with suspected bladder cancer.

[1]  Christian B. Woods,et al.  Analysis of repetitive element DNA methylation by MethyLight , 2005, Nucleic acids research.

[2]  Liang Cheng,et al.  Molecular Evidence Supporting Field Effect in Urothelial Carcinogenesis , 2005, Clinical Cancer Research.

[3]  W. Schulz,et al.  Causes and consequences of DNA hypomethylation in human cancer. , 2005, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[4]  Ishtiaq Rehman,et al.  Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  R. Knuechel,et al.  Deletions of chromosomes 9 and 8p in histologically normal urothelium of patients with bladder cancer. , 2005, European urology.

[6]  D. Heimburger,et al.  Race- and age-dependent alterations in global methylation of DNA in squamous cell carcinoma of the lung (United States) , 2003, Cancer Causes & Control.

[7]  W. Schulz,et al.  Decrease of DNA methyltransferase 1 expression relative to cell proliferation in transitional cell carcinoma , 2003, International journal of cancer.

[8]  L. Mariani,et al.  DNA demethylation is directly related to tumour progression: evidence in normal, pre-malignant and malignant cells from uterine cervix samples. , 2003, Oncology reports.

[9]  M. Ehrlich,et al.  DNA methylation in cancer: too much, but also too little , 2002, Oncogene.

[10]  Peter A. Jones,et al.  The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.

[11]  K. To,et al.  Hypermethylation of multiple genes in tumor tissues and voided urine in urinary bladder cancer patients. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[12]  J. Minna,et al.  Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features. , 2001, Cancer research.

[13]  P. Laird,et al.  Global and gene-specific epigenetic patterns in human bladder cancer genomes are relatively stable in vivo and in vitro over time. , 2001, Cancer research.

[14]  W. Schulz,et al.  DNA Methylation and the Mechanisms of CDKN2A Inactivation in Transitional Cell Carcinoma of the Urinary Bladder , 2000, Laboratory Investigation.

[15]  S. Groshen,et al.  Progressive increases in de novo methylation of CpG islands in bladder cancer. , 2000, Cancer research.

[16]  R. Löwer,et al.  DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas , 1999, British Journal of Cancer.

[17]  W. Schulz,et al.  Hypomethylation of L1 LINE sequences prevailing in human urothelial carcinoma. , 1996, Cancer research.